康惠制药: 康惠制药关于控股股东协议转让公司股份完成过户登记暨控制权拟发生变更的进展公告

Core Points - The controlling shareholder of Xi'an Kanghui Pharmaceutical Co., Ltd. will change to Yuehe Zhichuang after the completion of the share transfer and related governance adjustments [1][2] - The share transfer involves 21,973,600 shares, representing 22% of the total shares, at a price of RMB 24.70 per share [1][2] - The actual controllers will be Li Hongming and Wang Xuefang after the governance adjustments are completed [2][3] Share Transfer Details - The share transfer has been completed, with the shares transferred to Yuehe Zhichuang on July 8, 2025 [2] - Before the transfer, Kanghui Holdings held 36,706,237 shares (36.75%), which will reduce to 14,732,637 shares (14.75%) after the transfer [2] - Yuehe Zhichuang will hold 21,973,600 shares (22%) post-transfer [2] Governance Changes - The company will proceed with the adjustment of board members and the appointment of executives as per the supplementary agreement [2][3] - The final implementation of the governance changes remains uncertain until the adjustments are completed [3]